Chronic Respiratory Illnesses are a real and growing problem for the US Healthcare System. 38 million patients suffer with either COPD or Asthma. COPD alone is the 3rd leading cause of death in the US. Direct economic impact of over $50 Billion annually in the US. 30% driven by ER Visits hospital admissions/readmissions.
Total U.S. Costs (2008)
COPD 3rd Leading
Cause of Death
Readmissions Point To The Chronic and Reoccurring Cycle For Patients:
- The 30-day hospital readmission rate for COPD patients is approximately 25%
- 41% of all hospital readmissions are COPD
- Readmissions for COPD costs are 50% higher than the original admission
- For the most severe patients, readmission length of stay (LOS) is twice as long (8 days) and results in 10 times higher mortality rates
A Real Issue That Needs Real Attention:
And healthcare stakeholders are taking action
ACO’s are first introduced to
- Co-ordinate care
- Improve Quality
- Reduce Cost
Hospital Readmission Reduction Program Introduced to
- Decrease 30 Day readmission rates
- Reward top performers
- Penalize excessive readmission rate
Value Modifier Program Introduced to
- Incentivize providers on quality
- Penalize poor performers
- Initial program focused on groups of 100+ providers
Value Modifier Program Expands
- Groups of 10+ are now included
Quality focused Programs continue to expand and evolve
- Hospital readmission penalties exceed $428m
- ACO’s have grown to 800+
- Value Modifier Program covers all groups from solo+
PMD offers a Comprehensive Solution For All Stakeholders That is:
- Clinically Relevant
- Easy to Implement
- Financially Sound
Simple as 1, 2, 3
Integrates a 1) proven breakthrough in personal spirometry,
2) HIPAA-compliant data portal, and 3) comprehensive wellness management services
Spiro PD 2.0 Collects Data:
Tri-Trend, medication management, biometric alerts
Spiro PD, the first-ever personal spirometer, is highly interactive. It provides audio coaching to help patients perform the spirometry test completely and accurately. And it captures, wirelessly and in real time, data on compliance with each patient’s personal care plan plus critical Tri-Trend data.
Spiro PD 2.0 Delivers Data To PMD Portal:
Beyond archiving and offering access to data, the secure, HIPAA-compliant PMD Portal connects patients and their healthcare team to improve communications...and outcomes. Patients decide who gets their data for assessment of care needs in real time and revisions of care plans based on real-time evidence.
WMS Promotes Care Plan Compliance for Positive Outcomes:
WMS delivers a critically important first: remote, real-time lung health monitoring and management that improve communication, increase care plan compliance, plus support the documentation and achievement of quality measures, all to improve patient outcomes.
WMS monitors patient’s lung function and medication adherence, and provides alerts based upon the personalized care plan, as well as tracks and documents non face-to-face time spent by care team members reviewing patient data, care plans, and interventions. WMS disseminates data to HCPs, patients, and caregivers through portal alerts, email, or text messages.
Spiro PD 2.0 WMS Addresses The Most Critical
Pain Points For Providers:
Care Plan Compliance
Enhances Care Coordination
Personalized Care Plans
Real Time Interventions
Helps Prevent Exacerbation
Reduced Costly ER Visits
Promotes Financial Benefits
Helps Achieve Quality Measures
Supports CCM Reimbursement
Evidence of Benefits
PMD Healthcare is well established and utilized among some of
the largest Health-Systems across the United States
Approved With A Large Global Presence
A portable and personal device like Spiro PD may encourage and empower patients to better manage their lung health while also providing them with a sense of security and increased communication capabilities.
"A personal (spirometer) like Spiro PD encourages patients to be active participants in preserving their health."
"Before, I was more passive about my asthma. But Spiro PD lets me see trends and reminds me to take my medications on schedule."
There is a growing body of evidence in support of what we do
Recent studies have shown that proper and integrated care for patients with stage III and IV COPD disease can have a significant impact on outcomes.
- 57% reduction
- 59% reduction in
- 73% reduction in
- 20% increase in
- Emergency Room Visits
- Hospital Admissions
- Unscheduled Visits
- Medication Adherence
Spiro PD 2.0 and WMS Make Good Financial Sense!
For quality focused organizations and those in pay for performance and shared savings models,
Spiro PD 2.0 and WMS make solid financial sense.
Work with us to enhance care coordination, improve quality, reduce readmissions and improve outcomes.
Contact us today to receive a complimentary analysis specific to your organization demonstrating the clinical benefit, ease of implementation and financial benefits.